Compare NIO & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NIO | TECH |
|---|---|---|
| Founded | 2014 | 1976 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 9.2B |
| IPO Year | 2018 | 1989 |
| Metric | NIO | TECH |
|---|---|---|
| Price | $5.09 | $58.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | $6.73 | ★ $71.23 |
| AVG Volume (30 Days) | ★ 41.2M | 1.6M |
| Earning Date | 11-25-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $10,189,444,895.00 | $1,216,732,000.00 |
| Revenue This Year | $33.27 | $2.33 |
| Revenue Next Year | $50.24 | $7.05 |
| P/E Ratio | ★ N/A | $120.82 |
| Revenue Growth | ★ 14.90 | 3.85 |
| 52 Week Low | $3.02 | $46.01 |
| 52 Week High | $8.02 | $79.28 |
| Indicator | NIO | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 45.70 |
| Support Level | $4.86 | $58.54 |
| Resistance Level | $5.79 | $59.64 |
| Average True Range (ATR) | 0.18 | 1.45 |
| MACD | 0.09 | 0.04 |
| Stochastic Oscillator | 24.32 | 49.84 |
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.